{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T03:06:35Z","timestamp":1784257595475,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J NeuroIntervent Surg"],"accepted":{"date-parts":[[2025,8,13]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Endovascular thrombectomy (EVT) is the standard treatment for acute ischemic stroke (AIS) due to large vessel occlusion. However, many patients fail to achieve good outcomes, especially without first pass reperfusion. Intra-arterial thrombolytics such as recombinant tissue plasminogen activator (rtPA) and tirofiban have shown potential as adjunctive therapies. The aim of this study was to compare the in vitro effects of rtPA, tirofiban, and their sequential combination on EVT retrieved clots.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Human clot obtained during EVT was tested in an in vitro model of cerebral circulation. A three-dimensional printed arterial flow loop was used to replicate middle cerebral artery circulation. Clots were exposed to four treatment arms: plasma (control), rtPA, tirofiban, or both rtPA and tirofiban sequentially. Thrombolytic efficacy was quantified by clot weight reduction with multivariable statistical analyses adjusted by clinical variables.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>70 clots were collected and used to perform 172 thrombolytic experiments. Both rtPA and tirofiban significantly reduced clot weight (tirofiban 20.6%, rtPA 20.7%, P&lt;0.001), with a greater reduction when administered sequentially (37.9%, P&lt;0.001). The treatment arm was the only significant predictor of thrombolytic effect. Clinical variables showed no statistically significant associations, although occlusion location and diabetes showed trends toward an association with clot weight reduction.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>This study supports the use of clot based in vitro models with autologous plasma for standardized drug testing for patients with AIS. Sequential administration of rtPA and tirofiban resulted in greater clot degradation than either agent alone. Further studies are needed to confirm clinical applicability and optimize dual thrombolytic strategies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jnis-2025-023809","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T01:30:34Z","timestamp":1756085434000},"page":"1817-1823","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":1,"title":["Validation of an in vitro testing platform for intra-arterial thrombolytics on human thrombectomy retrieved clots"],"prefix":"10.1136","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-3195-9601","authenticated-orcid":false,"given":"Judith","family":"Cendrero","sequence":"first","affiliation":[{"name":"Stroke Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4278-8222","authenticated-orcid":false,"given":"Jiahui","family":"Li","sequence":"additional","affiliation":[{"name":"Stroke Research, Vall d\u2019Hebron Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Serodio","sequence":"additional","affiliation":[{"name":"Centro Hospitalar de Lisboa Ocidental EPE Servi\u00e7o de Neurologia, Lisbon, Portugal"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Marquez","sequence":"additional","affiliation":[{"name":"Stroke Research, Vall d\u2019Hebron Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3633-3002","authenticated-orcid":false,"given":"Alvaro","family":"Garcia-Tornel","sequence":"additional","affiliation":[{"name":"Stroke Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1309-0730","authenticated-orcid":false,"given":"Jesus","family":"Juega","sequence":"additional","affiliation":[{"name":"Stroke Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Meza","sequence":"additional","affiliation":[{"name":"Stroke Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3408-1297","authenticated-orcid":false,"given":"Santiago","family":"Ortega-Gutierrez","sequence":"additional","affiliation":[{"name":"Neuroloy, Neurosurgery, and Radiology, University of Iowa Hospitals and Clinics, Iowa City, Iowa, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1296-3731","authenticated-orcid":false,"given":"Riccardo","family":"Tiberi","sequence":"additional","affiliation":[{"name":"Stroke Research, Vall d\u2019Hebron Research Institute, Barcelona, Spain"},{"name":"Universitat Polit\u00e8cnica de Catalunya, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angel Guillermo","family":"Arevalo","sequence":"additional","affiliation":[{"name":"Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0192-3272","authenticated-orcid":false,"given":"Pere","family":"Canals","sequence":"additional","affiliation":[{"name":"Stroke Research, Vall d\u2019Hebron Research Institute, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriano","family":"Bonura","sequence":"additional","affiliation":[{"name":"Stroke Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jorge","family":"Pagola","sequence":"additional","affiliation":[{"name":"Stroke Unit, Vall d\u2019Hebron University Hospital, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9242-043X","authenticated-orcid":false,"given":"Marc","family":"Ribo","sequence":"additional","affiliation":[{"name":"Stroke Unit, Neurology, Hospital Vall d\u2019Hebron, Barcelona, Spain"},{"name":"Medicina, Universitat Aut\u00f2noma de Barcelona, Barcelona, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,8,24]]},"reference":[{"key":"2026071607151221000_18.8.1817.1","first-page":"795","article-title":"Global, regional, and national burden of stroke and its risk factors, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"20","year":"2019","journal-title":"Lancet Neurol"},{"key":"2026071607151221000_18.8.1817.2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.3340\/jkns.2023.0181","article-title":"Endovascular Thrombectomy for Acute Ischemic Stroke\u202f: Current Concept in Management","volume":"67","author":"Bae","year":"2024","journal-title":"J Korean Neurosurg Soc"},{"key":"2026071607151221000_18.8.1817.3","doi-asserted-by":"crossref","unstructured":"Bilgin C , Ibrahim M , Ghozy S , et al . Disability-free outcomes after mechanical thrombectomy: A systematic review and meta-analysis of the randomized controlled trials. Interv Neuroradiol 2024. doi:10.1177\/15910199231224826","DOI":"10.1177\/15910199231224826"},{"key":"2026071607151221000_18.8.1817.4","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019988","article-title":"Effect of First\u2010Pass Reperfusion on Outcome After Endovascular Treatment for Ischemic Stroke","volume":"10","author":"den Hartog","year":"2021","journal-title":"JAHA"},{"key":"2026071607151221000_18.8.1817.5","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.119.025088"},{"key":"2026071607151221000_18.8.1817.6","doi-asserted-by":"publisher","DOI":"10.1136\/neurintsurg-2020-016869"},{"key":"2026071607151221000_18.8.1817.7","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.124.045755"},{"key":"2026071607151221000_18.8.1817.8","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7264"},{"key":"2026071607151221000_18.8.1817.9","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A8374"},{"key":"2026071607151221000_18.8.1817.10","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.1645"},{"key":"2026071607151221000_18.8.1817.11","doi-asserted-by":"publisher","DOI":"10.1001\/jama.282.21.2003"},{"key":"2026071607151221000_18.8.1817.12","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.107.488551"},{"key":"2026071607151221000_18.8.1817.13","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2022.12584"},{"key":"2026071607151221000_18.8.1817.14","doi-asserted-by":"publisher","DOI":"10.2147\/CIA.S238769"},{"key":"2026071607151221000_18.8.1817.15","doi-asserted-by":"publisher","DOI":"10.3174\/ajnr.A7203"},{"key":"2026071607151221000_18.8.1817.16","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2021.666919","article-title":"Safety and Efficacy of Low-Dose Tirofiban Combined With Intravenous Thrombolysis and Mechanical Thrombectomy in Acute Ischemic Stroke: A Matched-Control Analysis From a Nationwide Registry","volume":"12","author":"Ma","year":"2021","journal-title":"Front Neurol"},{"key":"2026071607151221000_18.8.1817.17","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1161\/STROKEAHA.123.045880","article-title":"R-tPA Resistance Is Specific for Platelet-Rich Stroke Thrombi and Can Be Overcome by Targeting Nonfibrin Components","volume":"55","author":"Vandelanotte","year":"2024","journal-title":"Stroke"},{"key":"2026071607151221000_18.8.1817.18","doi-asserted-by":"publisher","DOI":"10.1038\/jcbfm.2014.241"},{"key":"2026071607151221000_18.8.1817.19","first-page":"2888","article-title":"Tirofiban combined with rt-PA intraarterial thrombolysis improves the recanalization rate of acute middle cerebral artery occlusion in rabbits","volume":"22","author":"Yu","year":"2018","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"2026071607151221000_18.8.1817.20","first-page":"104970","article-title":"Safety and efficacy of tirofiban combined with rtPA in patients with acute ischemic stroke","volume":"29","author":"Lin","year":"2020","journal-title":"J Stroke Cerebrovasc Dis"},{"key":"2026071607151221000_18.8.1817.21","first-page":"453","article-title":"Safety and preliminary efficacy of early tirofiban treatment after rtPA in acute ischemic stroke","volume":"6","author":"Chen","year":"2021","journal-title":"Stroke Vasc Neurol"},{"key":"2026071607151221000_18.8.1817.22","doi-asserted-by":"publisher","DOI":"10.1007\/s00228-019-02817-8"},{"key":"2026071607151221000_18.8.1817.23","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.110.599662"},{"key":"2026071607151221000_18.8.1817.24","doi-asserted-by":"publisher","DOI":"10.1016\/j.jvir.2018.08.021"},{"key":"2026071607151221000_18.8.1817.25","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.121.034289"},{"key":"2026071607151221000_18.8.1817.26","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1159\/000481578","article-title":"Ischemic Stroke: Histological Thrombus Composition and Pre-Interventional CT Attenuation Are Associated with Intervention Time and Rate of Secondary Embolism","volume":"44","author":"Sporns","year":"2017","journal-title":"Cerebrovasc Dis"},{"key":"2026071607151221000_18.8.1817.27","doi-asserted-by":"publisher","DOI":"10.1161\/STROKEAHA.116.013105"},{"key":"2026071607151221000_18.8.1817.28","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/jnis-2024-021654","article-title":"Intracranial thrombus composition is associated with occlusion location and endovascular treatment outcomes: results from ITACAT multicenter study","volume":"17","author":"Juega","year":"2025","journal-title":"J NeuroIntervent Surg"},{"key":"2026071607151221000_18.8.1817.29","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1056\/NEJMoa2411668","article-title":"Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion","volume":"392","author":"Goyal","year":"2025","journal-title":"N Engl J Med"},{"key":"2026071607151221000_18.8.1817.30","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1056\/NEJMoa2408954","article-title":"Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels","volume":"392","author":"Psychogios","year":"2025","journal-title":"N Engl J Med"}],"container-title":["Journal of NeuroInterventional Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jnis-2025-023809","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T02:38:28Z","timestamp":1784255908000},"score":1,"resource":{"primary":{"URL":"https:\/\/jnis.bmj.com\/lookup\/doi\/10.1136\/jnis-2025-023809"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,24]]},"references-count":30,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,7,16]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/jnis-2025-023809"],"URL":"https:\/\/doi.org\/10.1136\/jnis-2025-023809","relation":{},"ISSN":["1759-8478","1759-8486"],"issn-type":[{"value":"1759-8478","type":"print"},{"value":"1759-8486","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,24]]}}}